Clinical Trial Update: Clinical Trial of Teriparatide in Japan [Phase 2]

View source ↗

Summary

Update announcing the completion of a Phase 2 clinical trial of teriparatide for osteoporosis in Japan, sponsored by Eli Lilly.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Osteoporosis

Drugs mentioned

• Forteo (teriparatide)

Snippet

Sponsor: Eli Lilly and Company | Conditions: Osteoporosis | Phase 2 | Status: COMPLETED